Skip to main content

$3.18 0.09 (2.91%)

High

$3.18

Low

$3.12

Trades

1,177

Turnover

$3,954,133

Volume

1,248,327
30 June 2023 at 4:12pm
Register to track HLS and receive email alerts.

ASX Announcements (7d)

-

Twitter Mentions (7d)

0+

AFR Articles (7d)

1

News Articles (7d)

1+
Subject
HLS Ann: Update - Notification of buy-back - HLS

HLS Ann: Update - Notification of buy-back - HLS

HLS Ann: Update - Notification of buy-back - HLS

HLS Ann: Update - Notification of buy-back - HLS

HLS Ann: Update - Notification of buy-back - HLS

HLS Ann: Update - Notification of buy-back - HLS

HLS Ann: Update - Notification of buy-back - HLS

HLS Ann: Update - Notification of buy-back - HLS

HLS Ann: Update - Notification of buy-back - HLS

HLS Ann: Notification regarding unquoted securities - HLS

HLS Ann: Appendix 3X - Initial Director's Interest Notice

HLS Ann: Appointment of John Mattick as a Non-executive Director

HLS Ann: Sale of Adora Fertility to Liverpool Partners

HLS Article: Liverpool Partners snares Healius’ Adora Fertility second time around

HLS Article: Healius launches $100m share buy-back

HLS Ann: Healius announces on-market share buy-back

HLS Ann: Notification of buy-back - HLS

HLS Ann: Becoming a substantial holder

HLS Ann: Update - Dividend/Distribution - HLS

HLS Ann: Notification of cessation of securities - HLS

HLS Ann: Appendix 3Y Change of Directors Interest Notice

HLS Ann: Appendix 3Y Change of Directors Interest Notice

HLS Ann: Appendix 3Y Change of Directors Interest Notice

HLS Ann: Appendix 3Y Change of Directors Interest Notice

HLS Ann: Appendix 3Y Change of Directors Interest Notice

HLS Ann: Appendix 3Y Change of Directors Interest Notice

HLS Ann: Application for quotation of securities - HLS

HLS Article: Healius confident PCR tests will stay even in endemic stage

HLS Ann: HLS - Presentation of Half Year 2022 Results

HLS Ann: HLS - significant growth in results and progress on strategy

HLS Ann: Dividend/Distribution - HLS

HLS Ann: Half Yearly Report and Accounts

HLS Ann: Webcast details for 1H 2022 results announcement

HLS Ann: Completion of Agilex Biolabs acquisition

HLS Article: Healius inks $301m deal, Sonic raids US market

HLS Ann: Sale of Adora Fertility - termination

HLS Ann: Investor Presentation - Agilex acquisition

HLS Ann: Acquisition of Agilex Biolabs

HLS Ann: Final share buy-back notice - Appendix 3F

HLS Ann: Daily share buy-back notice - Appendix 3E

HLS Ann: Daily share buy-back notice - Appendix 3E

HLS Ann: Daily share buy-back notice - Appendix 3E

HLS Ann: Daily share buy-back notice - Appendix 3E

HLS Ann: Daily share buy-back notice - Appendix 3E

HLS Ann: Daily share buy-back notice - Appendix 3E

HLS Ann: Daily share buy-back notice - Appendix 3E

HLS Ann: Appendix 3Y Change of Directors Interest Notice

HLS Ann: Appendix 3Y Change of Directors Interest Notice

HLS Ann: Appendix 3Y Change of Directors Interest Notice

HLS Ann: Appendix 3Y Change of Directors Interest Notice

Register to track HLS and receive email alerts.

Similar Companies

AHX
BD1
CAJ
HLA
IDX
RHY
SHL
SLA
TTB